Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
aging
Biotech
Chugai inks $250M deal for Gero’s age-related disease targets
Chugai offered up to $250 million for the chance to develop antibodies against age-related disease targets identified by Gero's AI-driven platform.
Nick Paul Taylor
Jul 7, 2025 3:00am
NewLimit raises $130M to push liver mRNA med into clinic
May 6, 2025 11:00am
BioAge secures Novartis deal worth up to $550M biobucks
Dec 18, 2024 10:44am
RANKL cytokine makes the thymus more youthful in mice
Dec 5, 2024 11:45am
Advantage spins out anti-aging R&D to new biotech Klothea
Nov 25, 2024 11:56am
CAR-T cells prevent and reverse signs of metabolic age in mice
Jan 30, 2024 10:24am
